Interplay of parathyroid hormone‐related peptide (PTHrP), renal insufficiency and bulky disease in the pathogenesis of hypercalcemia in Hodgkin’s lymphoma (HL)

Abstract

European Journal of HaematologyVolume 85, Issue 4 p. 368-369 Interplay of parathyroid hormone-related peptide (PTHrP), renal insufficiency and bulky disease in the pathogenesis of hypercalcemia in Hodgkin’s lymphoma (HL) N. Chevalier, N. Chevalier Department of Hematology and Oncology, Freiburg University Medical Center, Freiburg, GermanySearch for more papers by this authorJ. Udi, J. Udi Department of Hematology and Oncology, Freiburg University Medical Center, Freiburg, GermanySearch for more papers by this authorM. Sigler, M. Sigler Department of Hematology and Oncology, Freiburg University Medical Center, Freiburg, GermanySearch for more papers by this authorM.E. Wolf, M.E. Wolf Department of Neurology, Mannheim University Medical Center, Mannheim, GermanySearch for more papers by this authorJ. Heinz, J. Heinz Department of Hematology and Oncology, Freiburg University Medical Center, Freiburg, GermanySearch for more papers by this authorA. Schmitt-Graeff, A. Schmitt-Graeff Pathology Department, Freiburg University Medical Center, Freiburg, GermanySearch for more papers by this authorJ. Seufert, J. Seufert Division of Endocrinology and Diabetology, University Hospital of Freiburg, Freiburg, GermanySearch for more papers by this authorR. Wäsch, R. Wäsch Department of Hematology and Oncology, Freiburg University Medical Center, Freiburg, GermanySearch for more papers by this authorM. Engelhardt, M. Engelhardt Department of Hematology and Oncology, Freiburg University Medical Center, Freiburg, GermanySearch for more papers by this author N. Chevalier, N. Chevalier Department of Hematology and Oncology, Freiburg University Medical Center, Freiburg, GermanySearch for more papers by this authorJ. Udi, J. Udi Department of Hematology and Oncology, Freiburg University Medical Center, Freiburg, GermanySearch for more papers by this authorM. Sigler, M. Sigler Department of Hematology and Oncology, Freiburg University Medical Center, Freiburg, GermanySearch for more papers by this authorM.E. Wolf, M.E. Wolf Department of Neurology, Mannheim University Medical Center, Mannheim, GermanySearch for more papers by this authorJ. Heinz, J. Heinz Department of Hematology and Oncology, Freiburg University Medical Center, Freiburg, GermanySearch for more papers by this authorA. Schmitt-Graeff, A. Schmitt-Graeff Pathology Department, Freiburg University Medical Center, Freiburg, GermanySearch for more papers by this authorJ. Seufert, J. Seufert Division of Endocrinology and Diabetology, University Hospital of Freiburg, Freiburg, GermanySearch for more papers by this authorR. Wäsch, R. Wäsch Department of Hematology and Oncology, Freiburg University Medical Center, Freiburg, GermanySearch for more papers by this authorM. Engelhardt, M. Engelhardt Department of Hematology and Oncology, Freiburg University Medical Center, Freiburg, GermanySearch for more papers by this author First published: 16 June 2010 https://doi.org/10.1111/j.1600-0609.2010.01490.x Prof. Dr. Monika Engelhardt, MD, Department of Hematology & Oncology, Freiburg University Medical Center, Hugstetter Strasse 55, 79106 Freiburg, Germany. Tel.: +49 761 2703246 Fax: +49 761 2703318; e-mail: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume85, Issue4October 2010Pages 368-369 RelatedInformation